삼진제약

005500KOSPI

66.7 / 100

Reference Date: 2026-09-08

Financial Score31.0 / 40

News Sentiment17.7 / 25

Momentum8.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but Revenue metrics are weak. Slightly up 2.6% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Samjin Pharmaceutical operates a diverse portfolio spanning OTC drugs, specialty pharmaceuticals, and APIs, leveraging its competitive edge in the pharmaceutical market. The company focuses on developing innovative treatments for age-related diseases and metabolic disorders, with key products including the anticoagulant 'Plaeris' and analgesic 'Geborin'. It is expanding into health foods and medical devices, and has enhanced its global production capabilities through the 2022 completion of its Osong facility.

Number of Employees

819people

Average Salary

81.5M KRW

Score Calculation Basis

Detailed Financial Score

PER

9.57Industry Average 15.006.5Point

Lower than industry avg (good)

PBR

0.86Industry Average 1.205.5Point

Lower than industry avg (good)

ROE

8.76Industry Average 8.004.0Point

In line with industry avg

Debt Ratio

11.36Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20257.0 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲2.9% (2-year basis)

Operating Profit Growth Rate

2.5 / 3

Avg ▲19.6% (2-year basis)

ROE Trend

3.5 / 4

Avg ROE 10.2% (improving, 3yr)

Detailed News Sentiment

16 totalPositive 11Neutral 5Negative 0Average Sentiment Score 70.9

Positive
韓기술수출 21조… 신약·플랫폼 빅딜 행진
삼진제약을 포함한 국내 제약바이오 기업들의 기술 수출 규모가 급증하여 긍정적인 시장 전망을 보임.
Positive
"벌써 21조" 글로벌 '빅딜'로 기술력 입증…K바이오 새역사 쓴다
삼진제약의 기술 수출 규모가 21조원을 돌파하며 글로벌 시장에서의 입지를 확고히 했다.
Neutral
껌 대신 비타민…"건강 우선" 편의점 계산대 앞 진열대도 바꿨다
편의점에서 건강식품 판매 전략 변화로 인해 삼진제약의 직접적인 영향은 제한적임.

Detailed Momentum

52-week position3.0Point

52w lower range (23%)

Current 18,780Won52-week high 24,70052-week low 17,010

1-month return4.0Point

1m +2.62% (slight rise)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

13 totalPositive 0Neutral 13Negative 0

Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-09-02
Neutral주식등의대량보유상황보고서(일반)2026-09-02
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-25
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-25
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-25